Tumor-Infiltrating Lymphocytes: A Promising Biomarker in Breast Cancer

被引：30

作者：

Heppner, Barbara Ingold ^{[1
]}

Loibl, Sibylle ^{[2
,3
]}

Denkert, Carsten ^{[1
,4
]}

机构：

[1] Charite, Inst Pathol, D-13353 Berlin, Germany

[2] German Breast Grp GBG Forsch GmbH, Neu Isenburg, Germany

[3] Sana Klinikum Offenbach, Offenbach, Germany

[4] German Canc Consortium DKTK, Berlin, Germany

来源：

BREAST CARE | 2016年 / 11卷 / 02期

关键词：

Breast cancer; Tumor-infiltrating lymphocytes; Adjuvant; Neoadjuvant; Pathological complete response; NEOADJUVANT CHEMOTHERAPY; PROGNOSTIC VALUE; PREDICTIVE-VALUE; PRIMARY THERAPY; TRASTUZUMAB; CARCINOMA; CONSENSUS; ANTIBODY;

D O I：

10.1159/000444357

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

There is clear evidence that the immune system plays an essential role in tumor defense. By determining tumor-infiltrating lymphocytes (TILs), the individual immunological response becomes more apparent and measurable. In breast cancer, high levels of TILs are associated with a more favorable clinical course. In this review, we describe how TILs are determined with emphasis on daily routine diagnostics. We further discuss their impact as a prognostic and predictive biomarker in the neoadjuvant and adjuvant therapy setting as well as in residual disease. We also discuss their potential future implications on further stratifying prognostic subgroups of breast cancer, thereby possibly influencing future therapy considerations. (C) 2016 S. Karger GmbH, Freiburg

引用

页码：96 / 100

页数：5

共 50 条

[41] Tumor-infiltrating lymphocytes as a prognostic biomarker in patients with ductal carcinoma in situ of the breast: Correspondence
Daungsupawong, Hinpetch
Wiwanitkit, Viroj
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2024,
[42] Tumor-infiltrating lymphocytes for the treatment of metastatic cancer
Foppen, M. H. Geukes
Donia, M.
Suane, I. M.
Haanen, J. B. A. G.
[J]. MOLECULAR ONCOLOGY, 2015, 9 (10) : 1918 - 1935
[43] Tumor-Infiltrating B Lymphocytes: Promising Immunotherapeutic Targets for Primary Liver Cancer Treatment
Milardi, Giulia
Lleo, Ana
[J]. CANCERS, 2023, 15 (07)
[44] Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art
Solinas, Cinzia
Carbognin, Luisa
De Silva, Pushpamali
Criscitiello, Carmen
Lambertini, Matteo
[J]. BREAST, 2017, 35 : 142 - 150
[45] Tumor infiltrating lymphocytes: current pathways to a standard biomarker in breast cancer
Tran, William T.
Lu, Fang-, I
Salgado, Roberto
[J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (12) : 1299 - 1301
[46] Tumor infiltrating lymphocytes (TILs) as prognostic biomarker in patients with breast cancer
Denkert, C.
[J]. BREAST, 2021, 56 : S5 - S5
[47] Usefulness of imaging findings in predicting tumor-infiltrating lymphocytes in patients with breast cancer
Filiz Çelebi
Filiz Agacayak
Alper Ozturk
Serkan Ilgun
Muhammed Ucuncu
Zeynep Erdogan Iyigun
Çetin Ordu
Kezban Nur Pilanci
Gul Alco
Serap Gultekin
Emetullah Cindil
Gursel Soybir
Fatma Aktepe
Vahit Özmen
[J]. European Radiology, 2020, 30 : 2049 - 2057
[48] The cytokine profile correlates with less tumor-infiltrating lymphocytes in luminal A breast cancer
Ishikawa, Eri
Watanabe, Takahiro
Kihara, Takako
Kuroiwa, Mamiko
Komatsu, Miki
Urano, Sayaka
Nagahashi, Masayuki
Hirota, Seiichi
Miyoshi, Yasuo
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2024,
[49] Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting
Garcia-Teijido, Paula
Luque Cabal, Maria
Pelaez Fernandez, Ignacio
Fernandez Perez, Yolanda
[J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2016, 10 : 31 - 39
[50] Automated Detection and Scoring of Tumor-Infiltrating Lymphocytes in Breast Cancer Histopathology Slides
Yosofvand, Mohammad
Khan, Sonia Y.
Dhakal, Rabin
Nejat, Ali
Moustaid-Moussa, Naima
Rahman, Rakhshanda Layeequr
Moussa, Hanna
[J]. CANCERS, 2023, 15 (14)

← 1 2 3 4 5 →